台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-元大-板橋三民 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-板橋三民 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.00184.8085.70-1272-0.37%
2025/01/15184.0000.0084.1012700.37%
2025/01/13085.5000.0083.9002690.01%
2024/12/202.189.6100.0089.802.12470.83%
2024/12/180.190.6000.0090.500.12440.02%
2024/12/09294.1000.0093.4022240.89%
2024/11/2600.003.196.0295.50-3.1193-1.61%
2024/11/2200.000.197.6097.50-0.1181-0.06%
2024/11/20397.9000.0097.8031721.74%
2024/11/135.295.633.495.5796.001.81361.31%
2024/11/110.193.700.493.8093.30-0.3112-0.27%
2024/11/0800.00189.9090.40-195-1.05%
2024/10/25289.2000.0089.4021171.70%
2024/10/23089.0000.0089.0001180.03%
2024/10/140.190.2500.0090.500.11330.04%
2024/10/0900.00091.4091.400135-0.02%
2024/10/0800.00091.6092.000133-0.02%
2024/09/100.487.3000.0086.700.41580.22%
2024/09/090.186.0000.0086.500.11590.04%
2024/09/04087.3000.0087.0001650.02%
2024/08/2100.00189.1089.40-1180-0.55%
2024/08/16089.9000.0089.3001860.01%
2024/08/1500.00189.0088.80-1188-0.53%
2024/08/120.191.0000.0089.900.12030.05%
2024/08/090.290.6000.0091.000.22040.10%
2024/08/0700.00390.7090.50-3210-1.43%
2024/07/260.291.1000.0091.500.22010.10%
2024/07/18192.3000.0092.7011990.50%
2024/07/16192.3000.0092.7011970.51%
2024/07/0500.000.291.1091.30-0.2203-0.11%
2024/07/01089.4000.0089.9002030.02%
2024/06/2800.000.190.3090.40-0.1205-0.05%
2024/06/20390.00390.4090.2002060.00%
2024/06/0300.00192.5092.40-1231-0.43%
2024/05/2200.00192.0092.40-1235-0.42%
2024/05/2100.00192.4092.10-1235-0.42%
2024/05/20194.00192.5093.4002330.00%
2024/05/13192.0000.0091.8012320.43%
2024/05/100.290.9500.0090.900.22400.08%
2024/05/08088.0000.0088.8002420.00%
2024/04/3000.00188.9089.00-1245-0.41%
2024/04/26189.40289.0589.00-1245-0.41%
2024/04/1000.00189.8089.50-1261-0.38%
2024/04/020.289.00189.2088.60-0.9259-0.33%
2024/03/260.287.6000.0087.200.22600.06%
2024/03/140.287.7000.0087.200.22860.07%
2024/03/11189.2000.0089.1012750.36%
2024/03/0800.00190.5090.40-1273-0.37%
2024/03/06590.8400.0090.9052701.85%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章